Operator Good day, ladies and gentlemen, and welcome to the Exelixis fourth quarter and fiscal year 2024 financial results ...

Delayed insurance claims and poor settlements often plague buyers of health and car insurance. The good news? Complaining ...

Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the fourth quarter and full year 2024.

SHANGHAI, China - 111, Inc. (NASDAQ:YI), a leading retail drugstore chain with a market capitalization of $61.5 million, announced today that it has regained compliance with NASDAQ's listing ...

Revenue for the fourth quarter and full year 2024 was $47.5 million and $179.0 million, respectively. The MRD business, which contributed 85% of revenue in the fourth quarter and 81% of revenue in the ...

There are several wounded at Nebakov Fortress who need your help, and you have to apply the correct treatments to save them.